Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity.

Johann PD, Vaegler M, Gieseke F, Mang P, Armeanu-Ebinger S, Kluba T, Handgretinger R, Müller I.

BMC Cancer. 2010 Sep 21;10:501. doi: 10.1186/1471-2407-10-501.

2.

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.

Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, Visai L, Moretta A, Del Fante C, Villa R, Ball LM, Fibbe WE, Maccario R, Locatelli F.

Haematologica. 2009 Dec;94(12):1649-60. doi: 10.3324/haematol.2009.006171. Epub 2009 Sep 22.

3.

Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.

Entrena A, Varas A, Vázquez M, Melen GJ, Fernández-Sevilla LM, García-Castro J, Ramírez M, Zapata AG, Vicente Á.

Cancer Lett. 2015 Jul 28;363(2):156-65. doi: 10.1016/j.canlet.2015.04.012. Epub 2015 Apr 23.

PMID:
25917077
4.

Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.

Saka Y, Furuhashi K, Katsuno T, Kim H, Ozaki T, Iwasaki K, Haneda M, Sato W, Tsuboi N, Ito Y, Matsuo S, Kobayashi T, Maruyama S.

Xenotransplantation. 2011 May-Jun;18(3):196-208. doi: 10.1111/j.1399-3089.2011.00640.x.

PMID:
21696449
5.

[Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].

Li F, Lyu J, Duan Y, Sun Y, Li D, Wang Y, Hu X, Xiao D.

Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):891-6. doi: 10.3760/cma.j.issn.0253-2727.2014.10.004. Chinese.

PMID:
25339324
6.

Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

Brune JC, Tormin A, Johansson MC, Rissler P, Brosjö O, Löfvenberg R, von Steyern FV, Mertens F, Rydholm A, Scheding S.

Int J Cancer. 2011 Jul 15;129(2):319-30. doi: 10.1002/ijc.25697. Epub 2010 Dec 1.

7.

The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.

Wang M, Yang Y, Yang D, Luo F, Liang W, Guo S, Xu J.

Immunology. 2009 Feb;126(2):220-32. doi: 10.1111/j.1365-2567.2008.02891.x. Epub 2008 Jun 24.

8.

Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties.

Siepe M, Thomsen AR, Duerkopp N, Krause U, Förster K, Hezel P, Beyersdorf F, Schlensak C, Südkamp NP, Bosse R, Niemeyer P.

Tissue Eng Part A. 2009 Jul;15(7):1787-96. doi: 10.1089/ten.tea.2008.0356.

PMID:
19132892
9.

Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains.

Barzilay R, Sadan O, Melamed E, Offen D.

Cytotherapy. 2009;11(4):435-42. doi: 10.1080/14653240902849796.

PMID:
19521891
10.

Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis.

Uckan D, Kilic E, Sharafi P, Kazik M, Kaya F, Erdemli E, Can A, Tezcaner A, Kocaefe C.

Cytotherapy. 2009;11(4):392-402. doi: 10.1080/14653240802582083.

PMID:
19337938
11.

Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.

Djouad F, Bony C, Häupl T, Uzé G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Rème T, Sany J, Jorgensen C, Noël D.

Arthritis Res Ther. 2005;7(6):R1304-15. Epub 2005 Sep 20.

12.

Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases.

Dimitriou H, Linardakis E, Martimianaki G, Stiakaki E, Perdikogianni CH, Charbord P, Kalmanti M.

Cytotherapy. 2008;10(2):125-33. doi: 10.1080/14653240701851332.

PMID:
18368591
13.

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells.

Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, Müller I.

BMC Cell Biol. 2010 Jan 28;11:11. doi: 10.1186/1471-2121-11-11.

14.

[Evaluation of differentiation potential of human bone marrow-derived mesenchymal stromal cells to cartilage and bone cells].

Kiliç E, Ceyhan T, Cetinkaya DU.

Acta Orthop Traumatol Turc. 2007 Aug-Oct;41(4):295-301. Turkish.

15.

Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.

Pradier A, Passweg J, Villard J, Kindler V.

Cell Transplant. 2011;20(5):681-91. doi: 10.3727/096368910X536545. Epub 2010 Nov 5.

PMID:
21054933
16.

Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

Kim J, Breunig MJ, Escalante LE, Bhatia N, Denu RA, Dollar BA, Stein AP, Hanson SE, Naderi N, Radek J, Haughy D, Bloom DD, Assadi-Porter FM, Hematti P.

Cytotherapy. 2012 Sep;14(8):925-35. doi: 10.3109/14653249.2012.684376. Epub 2012 May 9.

17.

Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.

Blanco B, Herrero-Sánchez MD, Rodríguez-Serrano C, García-Martínez ML, Blanco JF, Muntión S, García-Arranz M, Sánchez-Guijo F, Del Cañizo C.

Eur J Haematol. 2016 Dec;97(6):528-537. doi: 10.1111/ejh.12765. Epub 2016 Jun 1.

PMID:
27118602
18.

Evaluation of methods for cultivating limbal mesenchymal stromal cells.

Bray LJ, Heazlewood CF, Atkinson K, Hutmacher DW, Harkin DG.

Cytotherapy. 2012 Sep;14(8):936-47. doi: 10.3109/14653249.2012.684379. Epub 2012 May 15.

PMID:
22587591
19.

[Intracellular immunoglobulins in Namalwa and U266 cells co-cultivated with mesenchymal stromal cells].

Aĭzenshtadt AA, Ivanova NA, Bagaeva VV, Smolianinov AB, Pinevich AA, Samoĭlovich MP, Klimovich VB.

Tsitologiia. 2014;56(2):117-22. Russian.

PMID:
25509151
20.

A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.

Rizzo R, Campioni D, Stignani M, Melchiorri L, Bagnara GP, Bonsi L, Alviano F, Lanzoni G, Moretti S, Cuneo A, Lanza F, Baricordi OR.

Cytotherapy. 2008;10(4):364-75. doi: 10.1080/14653240802105299.

PMID:
18574769

Supplemental Content

Support Center